Eur Rev Med Pharmacol Sci 2022; 26 (14): 4948-4948
DOI: 10.26355/eurrev_202207_29278

Recommended revisions to the article “Prehabilitation and heart failure”

S. Nakao, J. Watanabe, S. Yoshihiro, S. Maniwa

Rehabilitation Department, Shimane University Hospital 89-1 Enyacho, Izumo, Shimane, Japan. shuri.0302@gmail.com

To cite this article

S. Nakao, J. Watanabe, S. Yoshihiro, S. Maniwa
Recommended revisions to the article “Prehabilitation and heart failure”

Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 - N. 14
Pages: 4948-4948
DOI: 10.26355/eurrev_202207_29278

Publication History

Published online: 27 Jul 2022

Keywords Related articles:

  1. Prehabilitation and heart failure: main outcomes in the COVID-19 era
  2. Prehabilitation and heart failure: perspective in primary outcomes, a randomized controlled trial
  3. Impact of QRS morphology on heart rate turbulence and heart rate variability after cardiac resynchronization therapy in patients with heart failure
  4. Influences of simvastatin on vascular endothelial function of patients with coronary heart disease complicated with congestive heart failure
  5. Diagnostic value of growth differentiation factor-15 and β2-microglobulin in children with congenital heart disease combined with chronic heart failure and its relationship with cardiac function